Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: A UNAIDS study
E. Delgado et al., Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: A UNAIDS study, AIDS RES H, 17(8), 2001, pp. 753-758
We report the first study on prevalence of antiretroviral drug-associated r
esistance mutations in Venezuela, Protease and reverse transcriptase (RT) c
oding regions were analyzed in DNA samples obtained from 100 HIV-1-infected
individuals. Primary resistance mutations to RT inhibitors were identified
in 26% of patients treated with these drugs, Transmission of HIV-1-resista
nt strains was detected in a drug-naive patient (3%), Primary resistance mu
tations to protease inhibitors (PIs) were present in 9% of the 44 PI-treate
d patients and in 1 PI-naive individual. Phylogenetic analysis of these sam
ples has resulted in the most extensive survey, to date, of HIV-1 genetic f
orms circulating in Venezuela, Ninety-nine samples clustered with subtype B
, and 1 individual harbored the first B/F recombinant virus reported in Ven
ezuela, with protease clustering with subtype F and RT with subtype B, In a
ddition, this isolate had a new insertion (Glu-34 duplication) in the prote
ase gene.